Copb1-facilitated axonal transport and translation of kappa opioid-receptor mRNA.
mRNA of kappa opioid receptor (KOR) can be transported to nerve fibers, including axons of dorsal root ganglia (DRG), and can be locally translated. Yeast three-hybrid screening identifies Copb1 as a kor mRNA-associated protein that form complexes with endogenous kor mRNA, which are colocalized in the soma and axons of DRG neurons. Axonal transport of kor mRNA is demonstrated, directly, by observing mobilization of biotin-labeled kor mRNA in Campenot chambers. Efficient transport of kor mRNA into the side chamber requires Copb1 and can be blocked by a drug that disrupts microtubules. The requirement for Copb1 in mobilizing kor mRNA is confirmed by using the MS2-GFP mRNA-tagging system. Furthermore, Copb1 also facilitates the translation of kor mRNA in the soma and axons. This study provides evidence for a microtubule-dependent, active axonal kor mRNA-transport process that involves Copb1 and can stimulate localized translation and suggests coupling of transport and translation of mRNAs destined to the remote areas such as axons.
Bi
Jing
J
Department of Pharmacology, University of Minnesota Medical School, 6-120 Jackson Hall, 321 Church Street SE, Minneapolis, MN 55455, USA.
Tsai
Nien-Pei
NP
Lu
Hsin-Yi
HY
Loh
Horace H
HH
Wei
Li-Na
LN
D000818:Animals; D001370:Axonal Transport; D002478:Cells, Cultured; D020756:Coatomer Protein / Q000235:genetics / Q000378:metabolism*; D051959:ELAV Proteins / Q000378:metabolism; D005724:Ganglia / Q000378:metabolism; D016547:Kinesins / Q000378:metabolism; D051379:Mice; D011485:Protein Binding; D014176:Protein Biosynthesis / Q000235:genetics*; D012333:RNA, Messenger; D017473:Receptors, Opioid, kappa / Q000235:genetics*; D046509:Tissue Culture Techniques
D020756:Coatomer Protein; C523489:Copb1 protein, mouse; D051959:ELAV Proteins; D012333:RNA, Messenger; D017473:Receptors, Opioid, kappa; D016547:Kinesins
Cell Signal. 2006 Nov;18(11):1815-33
16750901
J Neurosci. 2006 Sep 20;26(38):9743-9
16988045
J Cell Biol. 2003 Sep 15;162(6):1045-55
12975348
Mol Pharmacol. 1989 Aug;36(2):265-72
2549383
Mol Cell Biol. 1997 Apr;17(4):2158-65
9121465
Front Biosci. 2004 May 01;9:1665-79
14977578
Eur J Pharmacol. 1988 Sep 13;154(2):169-78
2906610
Neuron. 2001 Aug 2;31(2):261-75
11502257
Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15566-71
14673085
Proc Natl Acad Sci U S A. 2006 Dec 26;103(52):19919-24
17167054
J Neurosci. 1999 Apr 1;19(7):2658-64
10087079
Nature. 2005 Nov 24;438(7067):512-5
16306994
Biochem Pharmacol. 1997 Jul 1;54(1):181-7
9296365
FEBS Lett. 2006 Oct 2;580(22):5227-31
16963028
J Cell Biol. 2005 May 9;169(3):383-9
15866890
J Neurosci. 1997 Dec 15;17(24):9492-505
9391005
EMBO J. 2007 Mar 21;26(6):1522-31
17318180
EMBO J. 1997 Apr 15;16(8):2130-9
9155038
Neuron. 2001 Nov 20;32(4):683-96
11719208
Cell Cycle. 2003 Sep-Oct;2(5):412-4
12963828
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2100-5
12592035
J Neurosci. 2000 Sep 1;20(17):6385-93
10964944
J Neurosci. 2006 Jul 5;26(27):7139-42
16822968
J Neurobiol. 1997 Oct;33(4):395-410
9322157
J Neurosci. 1997 Feb 15;17(4):1282-90
9006972
Neuropharmacology. 2004;47 Suppl 1:312-23
15464147
Nat Neurosci. 2000 Nov;3(11):1079-84
11036263
Curr Opin Pharmacol. 2002 Feb;2(1):69-75
11786311
Nat Rev Neurosci. 2001 Dec;2(12):889-98
11733796
Mol Cell Biol. 2006 Jan;26(1):277-92
16354698
Neuron. 2001 Nov 8;32(3):463-75
11709157
Nat Struct Mol Biol. 2006 Jun;13(6):533-9
16715093
J Cell Sci. 2002 Aug 15;115(Pt 16):3235-40
12140255
Annu Rev Cell Dev Biol. 2004;20:87-123
15473836
J Neurosci. 2003 Apr 15;23(8):3251-61
12716932
J Cell Sci. 2004 Jan 26;117(Pt 3):381-8
14702384
J Cell Biol. 2002 Dec 23;159(6):915-21
12499351
Nat Cell Biol. 2004 Jul;6(7):585-91
15232591
Mol Pharmacol. 2000 Aug;58(2):388-98
10908307
Mol Pharmacol. 2003 Sep;64(3):594-9
12920195
Mol Pharmacol. 2000 Feb;57(2):401-8
10648651